Author:
Zhao T T,Le Francois B G,Goss G,Ding K,Bradbury P A,Dimitroulakos J
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference36 articles.
1. Amano M, Fukata Y, Kaibuchi K . (2000). Regulation and functions of Rho-associated kinase. Exp Cell Res 261: 44–51.
2. Blais JD, Filipenko V, Bi M, Harding HP, Ron D, Koumenis C et al. (2004). Activating transcription factor 4 is translationally regulated by hypoxic stress. Mol Cell Biol 24: 7469–7482.
3. Boulougouris P, Elder J . (2001). Epidermal growth factor receptor structure, regulation, mitogenic signalling and effects of activation. Anticancer Res 21: 2769–2775.
4. Breathnach OS, Freidlin B, Conley B, Green MR, Johnson DH, Gandara DR et al. (2001). Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J Clin Oncol 19: 1734–1742.
5. Cabebe E, Wakelee H . (2007). Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitors. Curr Treat Options Oncol 8: 15–27.
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献